(Q33932859)

30 July 2017

1 reference

title

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design (English)

1 reference

30 July 2017

16

A Privat

0 references

Naomi Kleitman

object named as

N Kleitman

11

0 references

Daniel Lammertse

object named as

D Lammertse

1

0 references

author name string

M H Tuszynski

2

1 reference

30 July 2017

J D Steeves

3

1 reference

30 July 2017

A Curt

4

1 reference

30 July 2017

J W Fawcett

5

1 reference

30 July 2017

C Rask

6

1 reference

30 July 2017

J F Ditunno

7

1 reference

30 July 2017

M G Fehlings

8

1 reference

30 July 2017

J D Guest

9

1 reference

30 July 2017

P H Ellaway

10

1 reference

30 July 2017

A R Blight

12

1 reference

30 July 2017

B H Dobkin

13

1 reference

30 July 2017

R Grossman

14

1 reference

30 July 2017

H Katoh

15

1 reference

30 July 2017

M Kalichman

17

1 reference

30 July 2017

International Campaign for Cures of Spinal Cord Injury Paralysis

18

1 reference

30 July 2017

language of work or name

1 reference

19 December 2006

1 reference

30 July 2017

1 reference

30 July 2017

45

1 reference

30 July 2017

3

1 reference

30 July 2017

232-242

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.sc.3102010

30 July 2017

0 references

cites work

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Biomarkers and surrogate markers: an FDA perspective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Absorption characteristics of sustained-release 4-aminopyridine (fampridine SR) in patients with chronic spinal cord injury

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4106695

Intrathecal administration of 4-aminopyridine in chronic spinal injured patients.

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

Phase 2 trial of sustained-release fampridine in chronic spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

SCIM--spinal cord independence measure: a new disability scale for patients with spinal cord lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3102010

Omental transposition in chronic spinal cord injury

21 January 2018

1 reference

12 December 2020

Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury

1 reference

12 December 2020

Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results

1 reference

12 December 2020

The Sygen multicenter acute spinal cord injury study

1 reference

12 December 2020

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.SC.3102010

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference